Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness (Q36431013)

14 August 2017

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness (English)

1 reference

14 August 2017

cervix uterine cancer

1 reference

4

Meijer CJ

1 reference

14 August 2017

van Ballegooijen M

1

1 reference

14 August 2017

van den Akker-van Marle ME

2

1 reference

14 August 2017

Warmerdam PG

3

1 reference

14 August 2017

Walboomers JM

5

1 reference

14 August 2017

Habbema JD

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

76

1 reference

14 August 2017

5

1 reference

14 August 2017

651-657

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1997.440

14 August 2017

0 references

cites work

Can papilloma virus testing be used to improve cervical cancer screening?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Sexually transmitted agents and cervical neoplasia in Colombia and Spain

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Human papillomavirus and invasive cervical cancer in Brazil

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Preventive Pap-smears: balancing costs, risks and benefits

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Human papillomavirus testing in primary cervical screening.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Economic aspects of cervical cancer screening.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Estimates of the worldwide incidence of eighteen major cancers in 1985.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228006

Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia

21 October 2018

1 reference

12 December 2020

Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions

1 reference

12 December 2020

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

12 December 2020

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

12 December 2020

Cancer in the European community and its member states

1 reference

12 December 2020

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

1 reference

12 December 2020

The management of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The Netherlands

1 reference

12 December 2020

Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears

1 reference

12 December 2020

Cervical-cancer screening: attendance and cost-effectiveness

1 reference

12 December 2020

Care and costs for advanced cervical cancer

1 reference

12 December 2020

Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia

1 reference

12 December 2020

Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.440

1 reference

14 August 2017

1 reference

14 August 2017

1 reference